Safety of Pharmacologic Mydriasis for Diabetic Retinopathy Screening - 2025 - AAO-ophtalmo | Cliniscan
Cliniscan
Solutions
Tarifs
Ressources
Se connecter
Essayer gratuitement
Cliniscan
Retour aux recommandations
AAO-ophtalmo
2025
Safety of Pharmacologic Mydriasis for Diabetic Retinopathy Screening - 2025
Document
Analyser ce document
